FDA Inspection 914497 - Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc. - February 06, 2015

This FDA Inspection record concerns Onyx Pharmaceuticals, Inc., a Subsidiary of Amgen, Inc., with an inspection on February 6, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.